CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset-Reference-Cited by-同舟云学术

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset

Published:2017-08-10 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Damkier Per^ORCID,Kjærsgaard Anders^ORCID,Barker Kimberly A.,Cronin-Fenton Deidre,Crawford Anatasha,Hellberg Ylva,Janssen Emilius A. M.,Langefeld Carl,Ahern Thomas P.,Lash Timothy L.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-08091-x.pdf

Reference58 articles.

1. American Cancer Society. Breast cancer at a glance, https://cancerstatisticscenter.cancer.org/#/cancer-site/Breast (Accessed 22/06/2017) (2017).

2. WHO Media Centre: Cancer fact sheet. http://www.who.int/mediacentre/factsheets/fs297/en/ (Accessed 22/06/2017) (2017).

3. Early Breast Cancer Trialists’ Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351, 1451–67 (1998).

4. Early Breast Cancer Trialists’ Collaborative, G.. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687–717 (2005).

5. Burstein, H. J. et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol 32, 2255–69 (2014).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and computational study of metal complex of α-mangostin as an anticancer candidate;Journal of Pharmacy & Pharmacognosy Research;2024-05-01

2. Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data;Clinical and Translational Science;2024-03

3. CYP2C19*17 association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients;Experimental Biology and Medicine;2023-09

4. Molecular Dynamic Simulation And 3d-Pharmacophore Modeling Of Alpha Mangostin And Its Derivatives Against Estrogen Alpha Receptor;Letters in Drug Design & Discovery;2023-02-20

5. Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective;Pharmacogenomics and Personalized Medicine;2022-06